Göran Gannedahl
Direktor/Vorstandsmitglied bei ECTIN RESEARCH AB
Profil
Göran Gannedahl is currently the Director at Ectin Research AB since 2022.
Previously, he worked as the VP-Medical, Regulatory Affairs & Research at Pronova BioPharma ASA from 2008 to 2012.
He holds a doctorate degree from Karolinska Institutet and the University of Uppsala.
Aktive Positionen von Göran Gannedahl
| Unternehmen | Position | Beginn |
|---|---|---|
| ECTIN RESEARCH AB | Direktor/Vorstandsmitglied | 01.05.2022 |
Ehemalige bekannte Positionen von Göran Gannedahl
| Unternehmen | Position | Ende |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Göran Gannedahl
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ECTIN RESEARCH AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
